Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1994 1
2004 2
2005 1
2009 1
2011 1
2012 4
2013 6
2014 6
2015 8
2016 7
2017 7
2018 12
2019 9
2020 12
2021 9
2022 10
2023 6
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

86 results

Results by year

Filters applied: . Clear all
Page 1
Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study.
Abou-Alfa GK, Macarulla T, Javle MM, Kelley RK, Lubner SJ, Adeva J, Cleary JM, Catenacci DV, Borad MJ, Bridgewater J, Harris WP, Murphy AG, Oh DY, Whisenant J, Lowery MA, Goyal L, Shroff RT, El-Khoueiry AB, Fan B, Wu B, Chamberlain CX, Jiang L, Gliser C, Pandya SS, Valle JW, Zhu AX. Abou-Alfa GK, et al. Among authors: whisenant j. Lancet Oncol. 2020 Jun;21(6):796-807. doi: 10.1016/S1470-2045(20)30157-1. Epub 2020 May 13. Lancet Oncol. 2020. PMID: 32416072 Free PMC article. Clinical Trial.
Final Overall Survival Efficacy Results of Ivosidenib for Patients With Advanced Cholangiocarcinoma With IDH1 Mutation: The Phase 3 Randomized Clinical ClarIDHy Trial.
Zhu AX, Macarulla T, Javle MM, Kelley RK, Lubner SJ, Adeva J, Cleary JM, Catenacci DVT, Borad MJ, Bridgewater JA, Harris WP, Murphy AG, Oh DY, Whisenant JR, Lowery MA, Goyal L, Shroff RT, El-Khoueiry AB, Chamberlain CX, Aguado-Fraile E, Choe S, Wu B, Liu H, Gliser C, Pandya SS, Valle JW, Abou-Alfa GK. Zhu AX, et al. Among authors: whisenant jr. JAMA Oncol. 2021 Nov 1;7(11):1669-1677. doi: 10.1001/jamaoncol.2021.3836. JAMA Oncol. 2021. PMID: 34554208 Free PMC article. Clinical Trial.
Ensartinib vs Crizotinib for Patients With Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer: A Randomized Clinical Trial.
Horn L, Wang Z, Wu G, Poddubskaya E, Mok T, Reck M, Wakelee H, Chiappori AA, Lee DH, Breder V, Orlov S, Cicin I, Cheng Y, Liu Y, Fan Y, Whisenant JG, Zhou Y, Oertel V, Harrow K, Liang C, Mao L, Selvaggi G, Wu YL. Horn L, et al. Among authors: whisenant jg. JAMA Oncol. 2021 Nov 1;7(11):1617-1625. doi: 10.1001/jamaoncol.2021.3523. JAMA Oncol. 2021. PMID: 34473194 Free PMC article. Clinical Trial.
Protective autophagy elicited by RAF→MEK→ERK inhibition suggests a treatment strategy for RAS-driven cancers.
Kinsey CG, Camolotto SA, Boespflug AM, Guillen KP, Foth M, Truong A, Schuman SS, Shea JE, Seipp MT, Yap JT, Burrell LD, Lum DH, Whisenant JR, Gilcrease GW 3rd, Cavalieri CC, Rehbein KM, Cutler SL, Affolter KE, Welm AL, Welm BE, Scaife CL, Snyder EL, McMahon M. Kinsey CG, et al. Among authors: whisenant jr. Nat Med. 2019 Apr;25(4):620-627. doi: 10.1038/s41591-019-0367-9. Epub 2019 Mar 4. Nat Med. 2019. PMID: 30833748 Free PMC article.
Synthetic helical peptide capping strategies.
Whisenant J, Burgess K. Whisenant J, et al. Chem Soc Rev. 2022 Jul 18;51(14):5795-5804. doi: 10.1039/d1cs01175h. Chem Soc Rev. 2022. PMID: 35786712 Review.
Translating preclinical MRI methods to clinical oncology.
Hormuth DA 2nd, Sorace AG, Virostko J, Abramson RG, Bhujwalla ZM, Enriquez-Navas P, Gillies R, Hazle JD, Mason RP, Quarles CC, Weis JA, Whisenant JG, Xu J, Yankeelov TE. Hormuth DA 2nd, et al. Among authors: whisenant jg. J Magn Reson Imaging. 2019 Nov;50(5):1377-1392. doi: 10.1002/jmri.26731. Epub 2019 Mar 29. J Magn Reson Imaging. 2019. PMID: 30925001 Free PMC article. Review.
MR Imaging Biomarkers in Oncology Clinical Trials.
Abramson RG, Arlinghaus LR, Dula AN, Quarles CC, Stokes AM, Weis JA, Whisenant JG, Chekmenev EY, Zhukov I, Williams JM, Yankeelov TE. Abramson RG, et al. Among authors: whisenant jg. Magn Reson Imaging Clin N Am. 2016 Feb;24(1):11-29. doi: 10.1016/j.mric.2015.08.002. Magn Reson Imaging Clin N Am. 2016. PMID: 26613873 Free PMC article. Review.
COVID-19 and Cancer: A Review of the Registry-Based Pandemic Response.
Desai A, Mohammed TJ, Duma N, Garassino MC, Hicks LK, Kuderer NM, Lyman GH, Mishra S, Pinato DJ, Rini BI, Peters S, Warner JL, Whisenant JG, Wood WA, Thompson MA. Desai A, et al. Among authors: whisenant jg. JAMA Oncol. 2021 Dec 1;7(12):1882-1890. doi: 10.1001/jamaoncol.2021.4083. JAMA Oncol. 2021. PMID: 34473192 Free PMC article. Review.
TERAVOLT: Thoracic Cancers International COVID-19 Collaboration.
Whisenant JG, Trama A, Torri V, De Toma A, Viscardi G, Cortellini A, Michielin O, Barlesi F, Dingemans AC, Van Meerbeeck J, Pancaldi V, Soo RA, Leighl NB, Peters S, Wakelee H, Garassino MC, Horn L. Whisenant JG, et al. Cancer Cell. 2020 Jun 8;37(6):742-745. doi: 10.1016/j.ccell.2020.05.008. Epub 2020 May 16. Cancer Cell. 2020. PMID: 32425702 Free PMC article.
Unconventional Secondary Structure Mimics: Ladder-Rungs.
Lin CM, Arancillo M, Whisenant J, Burgess K. Lin CM, et al. Among authors: whisenant j. Angew Chem Int Ed Engl. 2020 Jun 8;59(24):9398-9402. doi: 10.1002/anie.202002639. Epub 2020 Apr 20. Angew Chem Int Ed Engl. 2020. PMID: 32176815 Free PMC article.
86 results